New requirements and key points for review for research related to health information data in the Measures of Ethical Review of Life Sciences and Medical Research Involving Humans
10.12026/j.issn.1001-8565.2024.04.03
- VernacularTitle:《涉及人的生命科学和医学研究伦理审查办法》对健康信息数据相关研究的新要求及审查要点
- Author:
Lu CHEN
1
;
Yan HE
1
;
Fang XU
2
;
Jiyin ZHOU
3
Author Information
1. National Drug Clinical Trial Center， the Affiliated Hospital of Guizhou Medical University， Guiyang 550003， China
2. Ethics Committee， the Affiliated Hospital of Guizhou Medical University， Guiyang 550003， China
3. Clinical Medical Research Center， the Second Affiliated Hospital of Army Medical University， Chongqing 400037， China
- Publication Type:Journal Article
- Keywords:
Measures of Ethical Review of Life Sciences and Medical Research Involving Humans;
information data;
ethical review
- From:
Chinese Medical Ethics
2024;37(4):392-398
- CountryChina
- Language:Chinese
-
Abstract:
To further standardize the ethical review of life science and medical research involving humans， the National Health Commission， the Ministry of Education， the Ministry of Science and Technology， and the State Administration of Traditional Chinese Medicine jointly issued the Measures of the Ethical Review of Life Science and Medical Research Involving Humans in 2023. The provisions concerning research related to health information data within it include： emphasizing the protection of personal information and privacy rights， personal information can only be collected， stored， and used under the premise that research participants know and permit， and must not be disclosed to third-party without the authorization of research participants； the ethical committee should focus on reviewing the adequacy of confidentiality measures of personal information； for research that provides information and data or cooperation with external organizations， it is necessary to fully understand the research， conduct a full ethical review， and clarify the use， processing， and disposal after completion of information data through an agreement. The research institutions should improve the information data governance and supervision system in conjunction with the key points of information data management in the new regulations. The initial ethical review should focus on the risk-benefit ratio of the research， the reasonableness of the informed consent procedure， the feasibility of the opt-out procedure， the protection measures for the privacy of the research participants， and the data management capability of the research team. The knowledge training of researchers should be strengthened， policy advisory services should be provided for them， and even a unified information data management platform should be built for them from the overall level of research institutions. The ethical follow-up review emphasizes whether the researchers continue to protect the participant’s right to independent information or personal information， and privacy. It is believed that through a series of governance measures， the health information data of research participants in China will be better protected， thus safeguarding their legitimate rights and interests.
